Literature DB >> 10775146

Beating rate of isolated neonatal cardiomyocytes is regulated by the stable microtubule subset.

D R Webster1, D L Patrick.   

Abstract

We investigated the roles of microtubule (MT) dynamics (growth and shrinkage), the stable, nongrowing MT subset, the posttranslationally detyrosinated MT subset, and artificially elevated tubulin levels in the negative regulation of heart cell beating rate. We manipulated the MT populations in isolated, neonatal cardiomyocytes obtained from normal animals in several ways and then measured heart cell beating rate directly. We found that the stabilized population of MTs was sufficient to maintain a normal beating rate, whereas MT dynamics and detyrosination made no observable contribution. Furthermore, by directly and acutely increasing the level of tubulin within otherwise normally beating cells, we found that the increased tubulin (and MT) levels further depressed the beating rate. In conclusion, the stabilized MT subset is sufficient to maintain the normal beating rate in these cells, whereas increasing the MT density depresses it.

Mesh:

Substances:

Year:  2000        PMID: 10775146     DOI: 10.1152/ajpheart.2000.278.5.H1653

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  13 in total

1.  Post-translational modifications of tubulin and microtubule stability in adult rat ventricular myocytes and immortalized HL-1 cardiomyocytes.

Authors:  Souad Belmadani; Christian Poüs; Rodolphe Fischmeister; Pierre-François Méry
Journal:  Mol Cell Biochem       Date:  2004-03       Impact factor: 3.396

Review 2.  Mechanical modulation of cardiac microtubules.

Authors:  Ed White
Journal:  Pflugers Arch       Date:  2011-04-13       Impact factor: 3.657

3.  Postnatal Cardiovascular Consequences in the Offspring of Pregnant Rats Exposed to Smoking and Smoking Cessation Pharmacotherapies.

Authors:  Kathirvel Gopalakrishnan; Amar S More; Gary D Hankins; Tatiana N Nanovskaya; Sathish Kumar
Journal:  Reprod Sci       Date:  2016-10-12       Impact factor: 3.060

4.  Stable microtubules contribute to cardiac dysfunction in the streptozotocin-induced model of type 1 diabetes in the rat.

Authors:  Holly Shiels; Anthony O'Connell; M Anwar Qureshi; F Christopher Howarth; Ed White; Sarah Calaghan
Journal:  Mol Cell Biochem       Date:  2006-07-13       Impact factor: 3.396

5.  Augmented rififylin is a risk factor linked to aberrant cardiomyocyte function, short-QT interval and hypertension.

Authors:  Kathirvel Gopalakrishnan; Eric E Morgan; Shane Yerga-Woolwine; Phyllis Farms; Sivarajan Kumarasamy; Andrea Kalinoski; Xiaochen Liu; Jian Wu; Lijun Liu; Bina Joe
Journal:  Hypertension       Date:  2011-02-28       Impact factor: 10.190

6.  Sodium current modulation by a tubulin/GTP coupled process in rat neonatal cardiac myocytes.

Authors:  Delara Motlagh; Kris J Alden; Brenda Russell; Jesús García
Journal:  J Physiol       Date:  2002-04-01       Impact factor: 5.182

7.  Post-translational Modification in Muscular Dystrophies.

Authors:  Martina Sandonà; Valentina Saccone
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

8.  Post-translational modifications of cardiac tubulin during chronic heart failure in the rat.

Authors:  Souad Belmadani; Christian Poüs; Renée Ventura-Clapier; Rodolphe Fischmeister; Pierre-François Méry
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

9.  The p38/MAPK pathway regulates microtubule polymerization through phosphorylation of MAP4 and Op18 in hypoxic cells.

Authors:  Jiong-Yu Hu; Zhi-Gang Chu; Jian Han; Yong-ming Dang; Hong Yan; Qiong Zhang; Guang-ping Liang; Yue-Sheng Huang
Journal:  Cell Mol Life Sci       Date:  2009-11-14       Impact factor: 9.261

10.  Microtubule alteration is an early cellular reaction to the metabolic challenge in ischemic cardiomyocytes.

Authors:  David Vandroux; Céline Schaeffer; Cindy Tissier; Alain Lalande; Sandrine Bès; Luc Rochette; Pierre Athias
Journal:  Mol Cell Biochem       Date:  2004-03       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.